- Home
- BCAB vs SHLT Comparison
BCAB vs SHLT Comparison
Compare BCAB & SHLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCAB
- SHLT
- Stock Information
- Founded
- BCAB 2007
- SHLT 1987
- Country
- BCAB United States
- SHLT Israel
- Employees
- BCAB N/A
- SHLT N/A
- Industry
- BCAB Medicinal Chemicals and Botanical Products
- SHLT Business Services
- Sector
- BCAB Health Care
- SHLT Consumer Discretionary
- Exchange
- BCAB Nasdaq
- SHLT Nasdaq
- Market Cap
- BCAB 96.2M
- SHLT 63.6M
- IPO Year
- BCAB 2020
- SHLT N/A
- Fundamental
- Price
- BCAB $2.08
- SHLT $2.74
- Analyst Decision
- BCAB Strong Buy
- SHLT Strong Buy
- Analyst Count
- BCAB 2
- SHLT 1
- Target Price
- BCAB $6.00
- SHLT $11.00
- AVG Volume (30 Days)
- BCAB 1.6M
- SHLT 3.2K
- Earning Date
- BCAB 11-08-2024
- SHLT 09-26-2024
- Dividend Yield
- BCAB N/A
- SHLT N/A
- EPS Growth
- BCAB N/A
- SHLT N/A
- EPS
- BCAB N/A
- SHLT N/A
- Revenue
- BCAB N/A
- SHLT $55,939,000.00
- Revenue This Year
- BCAB N/A
- SHLT N/A
- Revenue Next Year
- BCAB N/A
- SHLT N/A
- P/E Ratio
- BCAB N/A
- SHLT N/A
- Revenue Growth
- BCAB N/A
- SHLT N/A
- 52 Week Low
- BCAB $1.14
- SHLT $2.60
- 52 Week High
- BCAB $4.02
- SHLT $10.44
- Technical
- Relative Strength Index (RSI)
- BCAB 55.80
- SHLT 37.68
- Support Level
- BCAB $1.87
- SHLT $2.64
- Resistance Level
- BCAB $2.13
- SHLT $2.89
- Average True Range (ATR)
- BCAB 0.12
- SHLT 0.12
- MACD
- BCAB 0.00
- SHLT 0.01
- Stochastic Oscillator
- BCAB 68.90
- SHLT 23.92
About BCAB BioAtla Inc.
BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its pipeline products comprise mecbotamab vedotin (BA3011), ozuriftamab vedotin (BA3021), and evalstotug (BA3071), and its Phase 1 clinical trial of BA3182 (CAB-EpCAM x CAB-CD3) and Bispecific antibody programs.
About SHLT SHL Telemedicine Ltd
SHL Telemedicine Ltd develops and markets personal telemedicine solutions. It consists of the transmission of medical data by an individual, from a remote location to a medical call center through telecommunication networks. The company offers solutions to subscribing patients, health insurance companies, hospitals, clinics, and physicians. It provides healthcare professional solutions to patients suffering from congestive heart failure, chronic obstructive pulmonary disease, and readmission solutions for reducing heart-related readmissions. In addition, consumer solutions include cardiac monitoring services. The company's geographical segments Israel, Europe, and the rest of the world, out of which majority revenue comes from Israel.